HistCite - The Kidney Transplant Papers

Add FileX ?

Use wildcard '*' to add more than one file at a time. For example, if you have file1, file2, etc. all in the same folder or directory; first, locate one of the files with the [Browse...] button. Then alter the file path in the box above to include '*' character (eg. file*). Wildcard '?' to blanket only one character works too.
Note: In Windows you can select multiple files and "drag and drop" them onto HistCite icon or shortcut. The program would start and load those files.

#	Date / Author / Journal	LCS	GCS	LCR	CR
1501	573 REIS HE, HEIMSOTH VH, HIRCHE H, EITELHUB.U INFLUENCE OF HEMODIALYSIS ON CELLULAR IMMUNODEFICIENCY IN UREMIC PATIENTS KLINISCHE WOCHENSCHRIFT. 1974; 52 (9): 437-443	1	13	5	23
1502	698 KAUFFMAN HM, LAWSON RK, ADAMS MB, SAMPSON D POST-TRANSPLANT HYPERSPLENISM TRANSPLANTATION PROCEEDINGS. 1979; 11 (1): 96-99	3	13	3	7
1503	821 OKA T, OHMORI Y, AIKAWA I, IOKA J, KADOTANI Y, et al. LIVING RELATED KIDNEY-TRANSPLANTS TREATED WITH CYCLOSPORINE TRANSPLANTATION PROCEEDINGS. 1983; 15 (4): 2501-2506	0	13	4	5
1504	831 TILNEY NL, KIRKMAN RL, ARAUJO JL, CARPENTER CB, MILFORD EL, et al. USE OF CYCLOSPORINE AND MONOCLONAL-ANTIBODIES IN CLINICAL RENAL-TRANSPLANTATION TRANSPLANTATION PROCEEDINGS. 1983; 15 (4): 2889-2895	4	13	3	15
1505	904 MAGNUS G, CAVALLINI M, HALBERG F, CORNELISSEN G, SUTHERLAND DER, et al. CIRCADIAN TOXICOLOGY OF CYCLOSPORIN TOXICOLOGY AND APPLIED PHARMACOLOGY. 1985; 77 (1): 181-185	0	13	2	18
1506	916 LAND W, CASTRO LA, WHITE DJG, HILLEBRAND G, HAMMER C, et al. CICLOSPORIN IN RENAL-TRANSPLANTATION PROGRESS IN ALLERGY. 1986; 38: 293-328	0	13	15	123
1507	943 JOHNSON RWG CYCLOSPORINE IN CADAVERIC RENAL-TRANSPLANTATION - 3-YEAR FOLLOW-UP OF A EUROPEAN MULTICENTER TRIAL TRANSPLANTATION PROCEEDINGS. 1986 OCT; 18 (5): 1229-1233	3	13	2	6
1508	974 JOHNSON CP, SIMMONS RL, SUTHERLAND DER, CANAFAX DM, ASCHER NL, et al. A RANDOMIZED TRIAL COMPARING CYCLOSPORINE WITH ANTILYMPHOBLAST-GLOBULIN AZATHIOPRINE FOR RENAL-ALLOGRAFT RECIPIENTS - RESULTS AT 2-1/2-6 YEARS TRANSPLANTATION. 1988 FEB; 45 (2): 380-385	1	13	4	37
1509	1009 NORMAN DJ THE CLINICAL ROLE OF OKT3 IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA. 1989 APR; 9 (1): 95-107	4	13	6	109
1510	1118 KAHAN BD TRANSPLANTATION TIMELINE - MANKINDS 3 MILLENNIA - ONE MAVERICKS 3 DECADES IN THE STRUGGLE AGAINST BIOCHEMICAL INDIVIDUALITY TRANSPLANTATION. 1991 JAN; 51 (1): 1-21	1	13	8	446
#	Date / Author / Journal	LCS	GCS	LCR	CR
1511	1208 BURRES NS, PREMACHANDRAN U, FRIGO A, SWANSON SJ, MOLLISON KW, et al. DUNAIMYCINS, A NEW COMPLEX OF SPIROKETAL 24-MEMBERED MACROLIDES WITH IMMUNOSUPPRESSIVE ACTIVITY .3. IMMUNOSUPPRESSIVE ACTIVITIES OF DUNAIMYCINS JOURNAL OF ANTIBIOTICS. 1991 DEC; 44 (12): 1331-1341	0	13	3	36
1512	1236 PERICO N, AMUCHASTEGUI CS, ZOJA C, BENIGNI A, MORIGI M, et al. FK-506 DOES NOT AFFECT THE GLOMERULAR-FILTRATION RATE AND RENAL PLASMA-FLOW IN THE RAT TRANSPLANTATION PROCEEDINGS. 1991 DEC; 23 (6): 3123-3125	3	13	6	18
1513	1238 YAMADA K, SUGISAKI Y, AKIMOTO M, YAMANAKA N SHORT-TERM FK-506-INDUCED MORPHOLOGICAL-CHANGES IN RAT KIDNEYS TRANSPLANTATION PROCEEDINGS. 1991 DEC; 23 (6): 3130-3132	2	13	2	9
1514	1258 NUSSLER AK, THOMSON AW IMMUNOMODULATORY AGENTS IN THE LABORATORY AND CLINIC PARASITOLOGY. 1992; 105: S5-S23	0	13	5	144
1515	1286 ERICZON BG, WIJNEN RMH, TIEBOSCH A, KUBOTA K, KOOTSTRA G, et al. THE EFFECT OF FK506 TREATMENT ON PANCREATICODUODENAL ALLOTRANSPLANTATION IN THE PRIMATE TRANSPLANTATION. 1992 JUN; 53 (6): 1184-1189	4	13	4	31
1516	1331 THOMSON AW, PROPPER DJ, WOO J, WHITING PH, MILTON JI, et al. COMPARATIVE EFFECTS OF RAPAMYCIN-FK-506 AND CYCLOSPORINE ON ANTIBODY-PRODUCTION, LYMPHOCYTE POPULATIONS AND IMMUNOGLOBULIN ISOTYPE SWITCHING IN THE RAT IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY. 1993; 15 (4): 355-369	0	13	5	26
1517	1348 STARZL TE LIVER ALLOTRANSPLANTATION AND XENOTRANSPLANTATION TRANSPLANTATION PROCEEDINGS. 1993 FEB; 25 (1): 15-17	1	13	4	18
1518	1365 STARZL TE, TODO S, Tzakis AG, Fung JJ THE TRANSPLANTATION OF GASTROINTESTINAL ORGANS GASTROENTEROLOGY. 1993 MAR; 104 (3): 673-679	1	13	11	39
1519	1376 KOUTOUBY R, ZUCKER C, ZUCKER K, BURKE G, NERY J, et al. MOLECULAR MONITORING OF THE IMMUNOSUPPRESSIVE EFFECTS OF CYCLOSPORINE IN RENAL-TRANSPLANT PATIENTS BY USING A QUANTITATIVE POLYMERASE CHAIN-REACTION HUMAN IMMUNOLOGY. 1993 APR; 36 (4): 227-234	0	13	1	18
1520	1535 KRENSKY AM, CLAYBERGER C TRANSPLANTATION IMMUNOLOGY PEDIATRIC CLINICS OF NORTH AMERICA. 1994 AUG; 41 (4): 819-839	0	13	8	120
#	Date / Author / Journal	LCS	GCS	LCR	CR
1521	1536 WHITE JD, TOSKE SG, YAKURA T SYNTHESIS OF THE C20-C34 SEGMENT OF THE IMMUNOSUPPRESSANT FK-506 VIA STEREOCONTROLLED ALDOL COUPLING - APPLICATION OF A REMOTE CHELATION EFFECT SYNLETT. 1994 AUG; (8): 591-593	0	13	6	57
1522	1585 KOCOSHIS SA SMALL-BOWEL TRANSPLANTATION IN INFANTS AND CHILDREN GASTROENTEROLOGY CLINICS OF NORTH AMERICA. 1994 DEC; 23 (4): 727-742	0	13	6	36
1523	1599 GOTO S, KAMADA N, LORD R, KOBAYASHI E, ENOSAWA S, et al. INDUCTION OF NATURAL CHIMERISM AFTER RETRANSPLANTATION OF THE LIVER IN RATS TRANSPLANTATION. 1994 DEC 15; 58 (11): 1230-1235	8	13	5	19
1524	1784 Yamada A, Murakami M, Ijima K, Yagita H, Okumura K, et al. Long-term acceptance of major histocompatibility complex-mismatched cardiac allograft induced by a low dose of CTLA4IgM plus FK506 MICROBIOLOGY AND IMMUNOLOGY. 1996; 40 (7): 513-518	1	13	3	27
1525	1819 Hariharan S, Alexander JW, Schroeder TJ, First MR Outcome of cadaveric renal transplantation by induction treatment in the cyclosporine era CLINICAL TRANSPLANTATION. 1996 APR; 10 (2): 186-190	0	13	5	29
1526	1830 Vischjager M, VanGulik TM, DeKleine RHJ, VanMarle J, Pfaffendorf M, et al. Experimental arterial allografting under low and therapeutic dosages of cyclosporine for immunosuppression TRANSPLANTATION. 1996 APR 27; 61 (8): 1138-1142	0	13	2	21
1527	1840 Okada K, Sakata H, Minamoto A, Fujihara M Effect of FK 506 administered tonically versus intramuscularly on suppression of the corneal immune reaction in rats OPHTHALMOLOGICA. 1996 MAY-JUN; 210 (3): 175-179	2	13	1	16
1528	1863 Shoker AS Immunopharmacologic therapy in renal transplantation PHARMACOTHERAPY. 1996 JUL-AUG; 16 (4): 562-575	1	13	10	151
1529	1966 Hariharan S, Peddi VR, Munda R, Demmy AM, Schroeder TJ, et al. Long-term renal and pancreas function with tacrolimus rescue therapy following kidney/pancreas transplantation TRANSPLANTATION PROCEEDINGS. 1997 FEB-MAR; 29 (1-2): 652-653	2	13	2	8
1530	1976 Rao AS, Fontes P, Iyengar A, Shapiro R, Dodson F, et al. Augmentation of chimerism with perioperative donor bone marrow infusion in organ transplant recipients: A 44 month follow-up TRANSPLANTATION PROCEEDINGS. 1997 FEB-MAR; 29 (1-2): 1184-1185	5	13	5	8
#	Date / Author / Journal	LCS	GCS	LCR	CR
1531	1995 Guo ZG, Chong ASF, Shen JK, Foster P, Sankary HN, et al. In vivo effects of leflunomide on normal pancreatic islet and syngeneic islet graft function TRANSPLANTATION. 1997 MAR 15; 63 (5): 716-721	1	13	6	25
1532	2008 Starzl TE, Demetris AJ, Murase N, Trucco M, Thomson AW, et al. Chimerism after organ transplantation CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION. 1997 MAY; 6 (3): 292-298	2	13	22	51
1533	2023 Guttmann RD, Fleming C Sequential biological immunosuppression. Induction therapy with rabbit antithymocyte globulin CLINICAL TRANSPLANTATION. 1997 JUN; 11 (3): 185-192	2	13	5	28
1534	2066 Tschernig T, Boeke K, Steinhoff G, Wonigeit K, Pabst R, et al. The lung as a source and a target organ for T- and B-lymphocytes AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY. 1997 OCT; 17 (4): 414-421	0	13	1	28
1535	2069 Norris S, Lawler M, McCann S, Hegarty J, OFarrelly C Donor type microchimerism is an infrequent event following liver transplantation and is not associated with graft acceptance HEPATOLOGY. 1997 OCT; 26 (4): 848-852	10	13	13	24
1536	2210 Reed W, Lee TH, Vichinsky EP, Lubin BH, Busch MP Sample suitability for the detection of minor white cell populations (microchimerism) by polymerase chain reaction TRANSFUSION. 1998 NOV-DEC; 38 (11-12): 1041-1045	4	13	2	22
1537	2240 Ravina A, Slezak L, Mirsky N, Anderson RA Control of steroid-induced diabetes with supplemental chromium JOURNAL OF TRACE ELEMENTS IN EXPERIMENTAL MEDICINE. 1999; 12 (4): 375-378	0	13	3	15
1538	2349 Joseph JM, Mosimann F, Tiercy JM, Roux E, Cerottini JP, et al. PCR confirmation of microchimerism and diagnosis of Graft versus Host Disease after liver transplantation TRANSPLANT INTERNATIONAL. 1999 NOV; 12 (6): 468-470	8	13	4	16
1539	2356 Platt JL, Nagayasu T Current status of xenotransplantation CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY. 1999 DEC; 26 (12): 1026-1032	0	13	2	61
1540	2398 Morales JM, Campistol JM, Andres A, Herrero JC Immunosuppression in older renal transplant patients DRUGS & AGING. 2000 APR; 16 (4): 279-287	0	13	4	57
#	Date / Author / Journal	LCS	GCS	LCR	CR
1541	2417 Jin YD, Fuller L, Esquenazi V, Blomberg BB, Rosen A, et al. Bone marrow cells inhibit the generation of autologous EBV-specific CTL HUMAN IMMUNOLOGY. 2000 JUN; 61 (6): 538-547	4	13	10	50
1542	2434 Groth CG, Brent LB, Calne RY, Dausset JB, Good RA, et al. Historic landmarks in clinical transplantation: Conclusions from the consensus conference at the University of California, Los Angeles WORLD JOURNAL OF SURGERY. 2000 JUL; 24 (7): 834-843	2	13	11	108
1543	2451 Morelli AE, Thomson AW Role of dendritic cells in the immune response against allografts CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION. 2000 NOV; 9 (6): 607-613	1	13	13	52
1544	2529 Jin TN, Toki J, Inaba M, Sugiura K, Fan TX, et al. Novel strategy for organ allografts using sublethal (7 Gy) irradiation followed by injection of donor bone marrow cells via portal vein TRANSPLANTATION. 2001 JUN 27; 71 (12): 1725-1731	1	13	6	46
1545	2553 Starzl TE The "privileged" liver and hepatic tolerogenicity LIVER TRANSPLANTATION. 2001 OCT; 7 (10): 918-920	4	13	9	29
1546	2615 Lun A, Cho MY, Muller C, Staffa G, Bechstein WO, et al. Diagnostic value of peripheral blood T-cell activation and soluble IL-2 receptor for acute rejection in liver transplantation CLINICA CHIMICA ACTA. 2002 JUN; 320 (1-2): 69-78	0	13	5	39
1547	2627 Okuda T, Ishikawa T, Azhipa O, Ichikawa N, Demetris AJ, et al. Early passenger leukocyte migration and acute immune reactions in the rat recipient spleen during liver engraftment: With particular emphasis on donor major histocompatibility complex class II+ cells TRANSPLANTATION. 2002 JUL 15; 74 (1): 103-111	5	13	17	53
1548	2675 Muramatsu K, Bishop AT, Sunagawa T, Valenzuela RG Fate of donor cells in vascularized bone grafts: Identification of systemic chimerism by the polymerase chain reaction PLASTIC AND RECONSTRUCTIVE SURGERY. 2003 FEB; 111 (2): 763-772	5	13	13	41
1549	2766 Calne R Cyclosporine as a milestone in immunosuppression TRANSPLANTATION PROCEEDINGS. 2004 MAR; 36 (2): 13S-15S	0	13	3	22
1550	2827 Kuball J, Theobald M, Ferreira EA, Hess G, Burg J, et al. Control of organ transplant-associated graft-versus-host disease by activated host lymphocyte infusions TRANSPLANTATION. 2004 DEC 27; 78 (12): 1774-1779	7	13	4	30
#	Date / Author / Journal	LCS	GCS	LCR	CR
1551	2920 Migita K, Maeda Y, Abiru S, Nakamura M, Komori A, et al. Immunosuppressant FK506 inhibits matrix metalloproteinase-9 induction in TNF-u-stimulated human hepatic stellate cells LIFE SCIENCES. 2006 APR 18; 78 (21): 2510-2515	0	13	2	41
1552	2943 Thaunat O, Badet L, El-Jaafari A, Kanitakis J, Dubernard JM, et al. Composite tissue allograft extends a helping hand to transplant immunologists AMERICAN JOURNAL OF TRANSPLANTATION. 2006 OCT; 6 (10): 2238-2242	1	13	2	30
1553	2977 Chan EY, Larson AM, Gernsheimer TB, Kowdley KV, Carithers RL, et al. Recipient and donor factors influence the incidence of graft-vs.-host disease in liver transplant patients LIVER TRANSPLANTATION. 2007 APR; 13 (4): 516-522	1	13	10	58
1554	3006 Hsu W, Shu SA, Gershwin E, Lian ZX The current immune function of hepatic dendritic cells CELLULAR & MOLECULAR IMMUNOLOGY. 2007 OCT; 4 (5): 321-328	0	13	10	75
1555	3017 Butt AN, Swaminathan R Overview of circulating nucleic acids in plasma/serum CIRCULATING NUCLEIC ACIDS IN PLASMA AND SERUM V. 2008; 1137: 236-242	0	13	5	48
1556	3044 Gras JM, Gerkens S, Beguin C, Janssen M, Smets F, et al. Steroid-free, tacrolimus-basiliximab immunosuppression in pediatric liver transplantation: Clinical and pharmacoeconomic study in 50 children LIVER TRANSPLANTATION. 2008 APR; 14 (4): 469-477	1	13	5	25
1557	3049 Mehrabi A, Fonouni H, Muller SA, Schmidt J Current concepts in transplant surgery: liver transplantation today LANGENBECKS ARCHIVES OF SURGERY. 2008 MAY; 393 (3): 245-260	0	13	4	93
1558	3076 Tan HP, Donaldson J, Ellis D, Moritz ML, Basu A, et al. Pediatric Living Donor Kidney Transplantation Under Alemtuzumab Pretreatment and Tacrolimus Monotherapy: 4- Year Experience TRANSPLANTATION. 2008 DEC 27; 86 (12): 1725-1731	0	13	13	52
1559	3085 Siemionow M, Klimczak A Tolerance and Future Directions for Composite Tissue Allograft Transplants: Part II PLASTIC AND RECONSTRUCTIVE SURGERY. 2009 JAN; 123 (1): 7E-17E	0	13	24	104
1560	3090 Demetris AJ, Lunz JG, Randhawa P, Wu T, Nalesnik M, et al. Monitoring of human liver and kidney allograft tolerance: a tissue/histopathology perspective TRANSPLANT INTERNATIONAL. 2009 JAN; 22 (1): 120-141	2	13	33	110
#	Date / Author / Journal	LCS	GCS	LCR	CR
1561	3094 Spada M, Riva S, Maggiore G, Cintorino D, Gridelli B Pediatric liver transplantation WORLD JOURNAL OF GASTROENTEROLOGY. 2009 FEB 14; 15 (6): 648-674	0	13	8	223
1562	3166 Naesens M, Sarwal MM Molecular diagnostics in transplantation NATURE REVIEWS NEPHROLOGY. 2010 OCT; 6 (10): 614-628	0	13	3	181
1563	91 ELLIS PP, FONKEN HA RETINOPATHIES OF CHRONIC GLOMERULONEPHRITIS - A STUDY OF CASES TREATED WITH RENAL TRANSPLANTATION ARCHIVES OF OPHTHALMOLOGY. 1966; 75 (1): 36-&	1	12	6	16
1564	120 BILLINGH.RE TUSSUE TRANSPLANTATION - SCOPE AND PROSPECT SCIENCE. 1966; 153 (3733): 266-&	1	12	2	47
1565	149 STARZL TE, MARCHIOR.TL, IWASAKI Y ATTRIBUTES OF CLINICALLY USED IMMUNOSUPPRESSIVE DRUGS - POSSIBLE FUTURE USES OF ANTILYMPHOID SERA FEDERATION PROCEEDINGS. 1967; 26 (3): 944-&	9	12	5	20
1566	211 JAMES K ANTI-LYMPHOCYTE SERUM CLINICA CHIMICA ACTA. 1968; 22 (1): 101-&	2	12	3	43
1567	222 WOLFJURG.P, KOPF AW, LIPKIN G, BART RS INFLUENCE OF ANTI-LYMPHOCYTE SERUM ON MALIGNANT MELANOMA JOURNAL OF INVESTIGATIVE DERMATOLOGY. 1968; 51 (6): 441-&	0	12	2	19
1568	254 DIETHELM AG, DUBERNAR.JM, BUSCH GJ, MURRAY JE CRITICAL RE-EVALUATION OF IMMUNOSUPPRESSIVE THERAPY IN CANINE RENAL ALLOGRAFTS SURGERY GYNECOLOGY AND OBSTETRICS WITH INTERNATIONAL ABSTRACTS OF SURGERY. 1968; 126 (4): 723-&	6	12	3	9
1569	285 FLETCHER EW, LECKY JW RADIOLOGICAL DEMONSTRATION OF UROLOGICAL COMPLICATIONS IN RENAL TRANSPLANTATION BRITISH JOURNAL OF RADIOLOGY. 1969; 42 (504): 886-&	1	12	2	17
1570	325 KASHIWAG.N, GROTH CG, AMEND JR, GECELTER L, BLANCHAR.H, et al. IMPROVEMENTS IN PREPARATION OF HETEROLOGOUS ANTILYMPHOCYTE GLOBULIN WITH SPECIAL REFERENCE TO ABSORPTION AND DIETHYLAMINOETHYL CELLULOSE BATCH PRODUCTION SURGERY. 1969; 65 (3): 477-&	5	12	4	14
#	Date / Author / Journal	LCS	GCS	LCR	CR
1571	346 GUTTMANN RD, LINDQUIS.RR, OCKNER SA RENAL TRANSPLANTATION IN INBRED RAT .12. A MECHANISM OF LONG-TERM SURVIVAL OF ALLOGRAFTS AFTER ANTITHYMOCYTE IMMUNOGLOBULIN TREATMENT TRANSPLANTATION. 1969; 8 (6): 837-&	1	12	2	19
1572	405 PATTERSO.JT, PISANO JC, DILUZIO NR REVERSAL OF ANTILYMPHOCYTIC SERUM-INDUCED IMMUNOSUPPRESSION BY MACROPHAGE ADMINISTRATION PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE. 1970; 135 (3): 831-&	0	12	2	32
1573	421 WEEKE B, WEEKE E, BENDIXEN G VARIATION IN 21 SERUM PROTEINS BEFORE AND AFTER RENAL TRANSPLANTATION .2. CHANGES DURING ACUTE REJECTION ACTA MEDICA SCANDINAVICA. 1971; 189 (1-2): 119-&	1	12	2	8
1574	431 NOZIK RA, OCONNOR GR EXPERIMENTAL OCULAR TOXOPLASMOSIS IN RABBIT .3. RECURRENT INFLAMMATION STIMULATED BY SYSTEMIC ADMINISTRATION OF ANTILYMPHOCYTE SERUM AND NORMAL HORSE SERUM ARCHIVES OF OPHTHALMOLOGY. 1971; 85 (6): 718-&	0	12	1	14
1575	434 JEEJEEBH.HF HETEROLOGOUS ANTILYMPHOCYTE SERUM - REVIEW CANADIAN JOURNAL OF SURGERY. 1971; 14 (1): 5-&	0	12	17	115
1576	478 CHALMERS AH, BURDORF T, MURRAY AW IMMUNOSUPPRESSION BY 9-ALKYL-6-THIOPURINES BIOCHEMICAL PHARMACOLOGY. 1972; 21 (19): 2662-&	0	12	2	25
1577	514 MYBURGH JA, SMIT JA HEPATIC ALLOTRANSPLANTATION IN BABOON .4. FURTHER STUDIES WITH POST-TRANSPLANT ADMINISTRATION OF DONOR BONE-MARROW AND A SOLUBLE DONOR SPLENIC ANTIGEN TRANSPLANTATION. 1972; 14 (2): 191-&	2	12	3	10
1578	583 DUNN DC, RANDALL GK PROLONGED ALLOGRAFT SURVIVAL FOLLOWING SPONTANEOUS RECOVERY FROM EARLY REJECTION TRANSPLANTATION. 1974; 17 (3): 306-312	0	12	1	26
1579	591 MICHEL RP, GUTTMANN RD, KNAACK J, KLASSEN J, BEAUDOIN JG, et al. ANTILYMPHOCYTE GLOBULIN IN RENAL-TRANSPLANTATION ARCHIVES OF SURGERY. 1975; 110 (1): 90-93	0	12	7	40
1580	611 DIETHELM AG, STERLING WA, ALDRETE JS, SHAW JF, MORGAN JM RETROSPECTIVE ANALYSIS OF 100 CONSECUTIVE PATIENTS UNDERGOING RELATED LIVING DONOR RENAL-TRANSPLANTATION ANNALS OF SURGERY. 1976; 183 (5): 502-510	0	12	10	25
#	Date / Author / Journal	LCS	GCS	LCR	CR
1581	623 SCHUSZIARRA V, ZIEKURSCH V, SCHLAMP R, SIEMENSEN HC PHARMACOKINETICS OF AZATHIOPRINE UNDER HEMODIALYSIS INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND BIOPHARMACY. 1976; 14 (4): 298-302	0	12	4	13
1582	628 ANDERSON B, SAMPSON C, CALLENDER CO SPONTANEOUS RENAL-ALLOGRAFT RUPTURE WITHOUT REJECTION - CASE-REPORT JOURNAL OF UROLOGY. 1976; 115 (6): 745-746	0	12	3	11
1583	732 STARZL TE, KLINTMALM GBG, IWATSUKI S, WEIL R, SCHROTER G LATE FOLLOW-UP AFTER THORACIC-DUCT DRAINAGE IN CADAVERIC RENAL- TRANSPLANTATION SURGERY GYNECOLOGY & OBSTETRICS. 1981; 153 (3): 377-382	6	12	4	27
1584	895 TELLIS VA, MATAS AJ, GLICHLICK D, QUINN T, SOBERMAN R, et al. CYCLOSPORINE - PRELIMINARY EXPERIENCE IN 79 PATIENTS WITH RENAL-TRANSPLANTS NEW YORK STATE JOURNAL OF MEDICINE. 1985; 85 (9): 531-534	1	12	5	17
1585	908 MAKOWKA L, GILAS T, FALK RE, MOFFAT FL, PHILLIPS MJ, et al. PREVENTION OF CYCLOSPORINE-INDUCED NEPHROTOXICITY IN RATS BY 16,16-DIMETHYL PROSTAGLANDIN-E2 TRANSPLANTATION PROCEEDINGS. 1985; 17 (1): 1381-1383	3	12	4	7
1586	955 KNECHTLE SJ, KEMPF K, BOLLINGER RR PEPTIC-ULCER DISEASE FOLLOWING RENAL-TRANSPLANTATION TRANSPLANTATION PROCEEDINGS. 1987 FEB; 19 (1): 2233-2236	1	12	4	9
1587	1004 MARGREITER R, BOSMULLER C, SPIELBERGER M, SCHMID T, KONIGSRAINER A CYCLOSPORINE (CY) MONOTHERAPY AFTER CADAVERIC RENAL-TRANSPLANTATION TRANSPLANTATION PROCEEDINGS. 1989 FEB; 21 (1): 1591-1593	2	12	1	8
1588	1013 DIEPERINK H CYCLOSPORINE-A NEPHROTOXICITY DANISH MEDICAL BULLETIN. 1989 JUN; 36 (3): 235-248	0	12	13	224
1589	1076 MARINO IR, FERLA G, CELLI S, STIEBER A, MUTTILLO I, et al. HYPERACUTE REJECTION OF RENAL DISCORDANT XENOGRAFT (PIG-TO-RABBIT) - MODEL ASSESSMENT AND REJECTION MECHANISMS TRANSPLANTATION PROCEEDINGS. 1990 JUN; 22 (3): 1071-1076	2	12	3	28
1590	1156 ROSSARO L, MAZZAFERRO V, SCOTTIFOGLIENI CL, WILLIAMS DS, SIMPLACEANU E, et al. EFFECT OF CYCLOSPORINE ON HEPATIC ENERGY STATUS AND ON FRUCTOSE METABOLISM AFTER PORTACAVAL-SHUNT IN DOG AS MONITORED BY P-31 NUCLEAR- MAGNETIC-RESONANCE SPECTROSCOPY INVIVO HEPATOLOGY. 1991 APR; 13 (4): 780-785	0	12	3	38
#	Date / Author / Journal	LCS	GCS	LCR	CR
1591	1235 HEBERT MF, ASCHER NL, LAKE JR, ROBERTS JP EFFICACY AND TOXICITY OF FK-506 FOR THE TREATMENT OF RESISTANT REJECTION IN LIVER-TRANSPLANT PATIENTS TRANSPLANTATION PROCEEDINGS. 1991 DEC; 23 (6): 3109-3110	4	12	2	4
1592	1272 TAKAORI K, NIO Y, INOUE K, TUN T, FUKUMOTO M, et al. A COMPARATIVE-STUDY ON IMMUNOSUPPRESSIVE EFFECTS OF CYCLOSPORINE-A AND FK-506 ON PERIPHERAL-BLOOD LYMPHOCYTES IN DOGS BIOTHERAPY. 1992 MAR; 4 (2): 129-137	1	12	6	49
1593	1284 HIRAI T, WADA H, HASEGAWA S, INUI K, YOKOMISE H, et al. THE IMMUNOSUPPRESSIVE EFFECT OF FK-506 ON CANINE LUNG TRANSPLANTATION JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY. 1992 JUN; 103 (6): 1127-1135	3	12	5	23
1594	1352 STARZL TE, MURASE N, DEMETRIS AJ, GIORDA R, VALDIVIA L, et al. DRUG DEVELOPMENT AND TESTING IN RELATION TO CELL-MIGRATION AND CHIMERISM TRANSPLANTATION PROCEEDINGS. 1993 FEB; 25 (1): 469-472	8	12	5	12
1595	1364 TAMURA K, WOO J, MURASE N, CARRIERI G, NALESNIK MA, et al. SUPPRESSION OF AUTOIMMUNE THYROID-DISEASE BY FK-506 - INFLUENCE ON THYROID-INFILTRATING CELLS, ADHESION MOLECULE EXPRESSION AND ANTITHYROGLOBULIN ANTIBODY-PRODUCTION CLINICAL AND EXPERIMENTAL IMMUNOLOGY. 1993 MAR; 91 (3): 368-375	3	12	6	32
1596	1384 WINKLER M, SCHULZE F, JOST U, RINGE B, PICHLMAYR R ANEMIA ASSOCIATED WITH FK-506 IMMUNOSUPPRESSION LANCET. 1993 APR 17; 341 (8851): 1035-1036	1	12	1	3
1597	1417 MEISER B, REICHART B GRAFT VESSEL DISEASE - THE IMPACT OF IMMUNOSUPPRESSION AND POSSIBLE TREATMENT STRATEGIES IMMUNOLOGICAL REVIEWS. 1993 AUG; 134: 99-116	0	12	3	75
1598	1516 ABUELMAGD K, TODO S, Tzakis AG, FURUKAWA H, NOUR B, et al. REJECTION OF HUMAN INTESTINAL ALLOGRAFTS - ALONE OR IN COMBINATION WITH THE LIVER TRANSPLANTATION PROCEEDINGS. 1994 JUN; 26 (3): 1430-1431	1	12	2	10
1599	1553 SUGIYAMA E, SUZUKI H, TUNRU IS, YAMASHITA N, HORI T, et al. FK506, AN IMMUNOSUPPRESSANT, PARTIALLY INHIBITS INTERLEUKIN-6 PRODUCTION BY ADHERENT RHEUMATOID SYNOVIAL- CELLS JOURNAL OF RHEUMATOLOGY. 1994 SEP; 21 (9): 1597-1601	0	12	5	29
1600	1700 NISCO SJ, HISSINK RJ, VRIENS PW, HOYT EG, REITZ BA, et al. IN-VIVO STUDIES OF THE MAINTENANCE OF PERIPHERAL TRANSPLANT TOLERANCE AFTER CYCLOSPORINE - RADIOSENSITIVE ANTIGEN-SPECIFIC SUPPRESSOR CELLS MEDIATE LASTING GRAFT PROTECTION AGAINST PRIMED EFFECTOR-CELLS TRANSPLANTATION. 1995 MAY 27; 59 (10): 1444-1452	0	12	5	57

Date / Author / Journal

LCS

GCS

LCR

1501

573 REIS HE, HEIMSOTH VH, HIRCHE H, EITELHUB.U

INFLUENCE OF HEMODIALYSIS ON CELLULAR IMMUNODEFICIENCY IN UREMIC PATIENTS

KLINISCHE WOCHENSCHRIFT. 1974; 52 (9): 437-443

1502

698 KAUFFMAN HM, LAWSON RK, ADAMS MB, SAMPSON D

POST-TRANSPLANT HYPERSPLENISM

TRANSPLANTATION PROCEEDINGS. 1979; 11 (1): 96-99

1503

821 OKA T, OHMORI Y, AIKAWA I, IOKA J, KADOTANI Y, et al.

TRANSPLANTATION PROCEEDINGS. 1983; 15 (4): 2501-2506

1504

831 TILNEY NL, KIRKMAN RL, ARAUJO JL, CARPENTER CB, MILFORD EL, et al.

USE OF CYCLOSPORINE AND MONOCLONAL-ANTIBODIES IN CLINICAL RENAL-TRANSPLANTATION

TRANSPLANTATION PROCEEDINGS. 1983; 15 (4): 2889-2895

1505

904 MAGNUS G, CAVALLINI M, HALBERG F, CORNELISSEN G, SUTHERLAND DER, et al.

CIRCADIAN TOXICOLOGY OF CYCLOSPORIN

TOXICOLOGY AND APPLIED PHARMACOLOGY. 1985; 77 (1): 181-185

1506

916 LAND W, CASTRO LA, WHITE DJG, HILLEBRAND G, HAMMER C, et al.

CICLOSPORIN IN RENAL-TRANSPLANTATION

PROGRESS IN ALLERGY. 1986; 38: 293-328

123

1507

943 JOHNSON RWG

CYCLOSPORINE IN CADAVERIC RENAL-TRANSPLANTATION - 3-YEAR FOLLOW-UP OF A EUROPEAN MULTICENTER TRIAL

TRANSPLANTATION PROCEEDINGS. 1986 OCT; 18 (5): 1229-1233

1508

974 JOHNSON CP, SIMMONS RL, SUTHERLAND DER, CANAFAX DM, ASCHER NL, et al.

A RANDOMIZED TRIAL COMPARING CYCLOSPORINE WITH ANTILYMPHOBLAST-GLOBULIN AZATHIOPRINE FOR RENAL-ALLOGRAFT RECIPIENTS - RESULTS AT 2-1/2-6 YEARS

TRANSPLANTATION. 1988 FEB; 45 (2): 380-385

1509

1009 NORMAN DJ

THE CLINICAL ROLE OF OKT3

IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA. 1989 APR; 9 (1): 95-107

109

1510

1118 KAHAN BD

TRANSPLANTATION TIMELINE - MANKINDS 3 MILLENNIA - ONE MAVERICKS 3 DECADES IN THE STRUGGLE AGAINST BIOCHEMICAL INDIVIDUALITY

TRANSPLANTATION. 1991 JAN; 51 (1): 1-21

446

Date / Author / Journal

LCS

GCS

LCR

1511

1208 BURRES NS, PREMACHANDRAN U, FRIGO A, SWANSON SJ, MOLLISON KW, et al.

DUNAIMYCINS, A NEW COMPLEX OF SPIROKETAL 24-MEMBERED MACROLIDES WITH IMMUNOSUPPRESSIVE ACTIVITY .3. IMMUNOSUPPRESSIVE ACTIVITIES OF DUNAIMYCINS

JOURNAL OF ANTIBIOTICS. 1991 DEC; 44 (12): 1331-1341

1512

1236 PERICO N, AMUCHASTEGUI CS, ZOJA C, BENIGNI A, MORIGI M, et al.

FK-506 DOES NOT AFFECT THE GLOMERULAR-FILTRATION RATE AND RENAL PLASMA-FLOW IN THE RAT

TRANSPLANTATION PROCEEDINGS. 1991 DEC; 23 (6): 3123-3125

1513

1238 YAMADA K, SUGISAKI Y, AKIMOTO M, YAMANAKA N

SHORT-TERM FK-506-INDUCED MORPHOLOGICAL-CHANGES IN RAT KIDNEYS

TRANSPLANTATION PROCEEDINGS. 1991 DEC; 23 (6): 3130-3132

1514

1258 NUSSLER AK, THOMSON AW

IMMUNOMODULATORY AGENTS IN THE LABORATORY AND CLINIC

PARASITOLOGY. 1992; 105: S5-S23

144

1515

1286 ERICZON BG, WIJNEN RMH, TIEBOSCH A, KUBOTA K, KOOTSTRA G, et al.

THE EFFECT OF FK506 TREATMENT ON PANCREATICODUODENAL ALLOTRANSPLANTATION IN THE PRIMATE

TRANSPLANTATION. 1992 JUN; 53 (6): 1184-1189

1516

1331 THOMSON AW, PROPPER DJ, WOO J, WHITING PH, MILTON JI, et al.

COMPARATIVE EFFECTS OF RAPAMYCIN-FK-506 AND CYCLOSPORINE ON ANTIBODY-PRODUCTION, LYMPHOCYTE POPULATIONS AND IMMUNOGLOBULIN ISOTYPE SWITCHING IN THE RAT

IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY. 1993; 15 (4): 355-369

1517

1348 STARZL TE

LIVER ALLOTRANSPLANTATION AND XENOTRANSPLANTATION

TRANSPLANTATION PROCEEDINGS. 1993 FEB; 25 (1): 15-17

1518

1365 STARZL TE, TODO S, Tzakis AG, Fung JJ

THE TRANSPLANTATION OF GASTROINTESTINAL ORGANS

GASTROENTEROLOGY. 1993 MAR; 104 (3): 673-679

1519

1376 KOUTOUBY R, ZUCKER C, ZUCKER K, BURKE G, NERY J, et al.

MOLECULAR MONITORING OF THE IMMUNOSUPPRESSIVE EFFECTS OF CYCLOSPORINE IN RENAL-TRANSPLANT PATIENTS BY USING A QUANTITATIVE POLYMERASE CHAIN-REACTION

HUMAN IMMUNOLOGY. 1993 APR; 36 (4): 227-234

1520

1535 KRENSKY AM, CLAYBERGER C

TRANSPLANTATION IMMUNOLOGY

PEDIATRIC CLINICS OF NORTH AMERICA. 1994 AUG; 41 (4): 819-839

120

Date / Author / Journal

LCS

GCS

LCR

1521

1536 WHITE JD, TOSKE SG, YAKURA T

SYNTHESIS OF THE C20-C34 SEGMENT OF THE IMMUNOSUPPRESSANT FK-506 VIA STEREOCONTROLLED ALDOL COUPLING - APPLICATION OF A REMOTE CHELATION EFFECT

SYNLETT. 1994 AUG; (8): 591-593

1522

1585 KOCOSHIS SA

SMALL-BOWEL TRANSPLANTATION IN INFANTS AND CHILDREN

GASTROENTEROLOGY CLINICS OF NORTH AMERICA. 1994 DEC; 23 (4): 727-742

1523

1599 GOTO S, KAMADA N, LORD R, KOBAYASHI E, ENOSAWA S, et al.

INDUCTION OF NATURAL CHIMERISM AFTER RETRANSPLANTATION OF THE LIVER IN RATS

TRANSPLANTATION. 1994 DEC 15; 58 (11): 1230-1235

1524

1784 Yamada A, Murakami M, Ijima K, Yagita H, Okumura K, et al.

Long-term acceptance of major histocompatibility complex-mismatched cardiac allograft induced by a low dose of CTLA4IgM plus FK506

MICROBIOLOGY AND IMMUNOLOGY. 1996; 40 (7): 513-518

1525

1819 Hariharan S, Alexander JW, Schroeder TJ, First MR

Outcome of cadaveric renal transplantation by induction treatment in the cyclosporine era

CLINICAL TRANSPLANTATION. 1996 APR; 10 (2): 186-190

1526

1830 Vischjager M, VanGulik TM, DeKleine RHJ, VanMarle J, Pfaffendorf M, et al.

Experimental arterial allografting under low and therapeutic dosages of cyclosporine for immunosuppression

TRANSPLANTATION. 1996 APR 27; 61 (8): 1138-1142

1527

1840 Okada K, Sakata H, Minamoto A, Fujihara M

Effect of FK 506 administered tonically versus intramuscularly on suppression of the corneal immune reaction in rats

OPHTHALMOLOGICA. 1996 MAY-JUN; 210 (3): 175-179

1528

1863 Shoker AS

Immunopharmacologic therapy in renal transplantation

PHARMACOTHERAPY. 1996 JUL-AUG; 16 (4): 562-575

151

1529

1966 Hariharan S, Peddi VR, Munda R, Demmy AM, Schroeder TJ, et al.

Long-term renal and pancreas function with tacrolimus rescue therapy following kidney/pancreas transplantation

TRANSPLANTATION PROCEEDINGS. 1997 FEB-MAR; 29 (1-2): 652-653

1530

1976 Rao AS, Fontes P, Iyengar A, Shapiro R, Dodson F, et al.

Augmentation of chimerism with perioperative donor bone marrow infusion in organ transplant recipients: A 44 month follow-up

TRANSPLANTATION PROCEEDINGS. 1997 FEB-MAR; 29 (1-2): 1184-1185

Date / Author / Journal

LCS

GCS

LCR

1531

1995 Guo ZG, Chong ASF, Shen JK, Foster P, Sankary HN, et al.

In vivo effects of leflunomide on normal pancreatic islet and syngeneic islet graft function

TRANSPLANTATION. 1997 MAR 15; 63 (5): 716-721

1532

2008 Starzl TE, Demetris AJ, Murase N, Trucco M, Thomson AW, et al.

Chimerism after organ transplantation

CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION. 1997 MAY; 6 (3): 292-298

1533

2023 Guttmann RD, Fleming C

Sequential biological immunosuppression. Induction therapy with rabbit antithymocyte globulin

CLINICAL TRANSPLANTATION. 1997 JUN; 11 (3): 185-192

1534

2066 Tschernig T, Boeke K, Steinhoff G, Wonigeit K, Pabst R, et al.

The lung as a source and a target organ for T- and B-lymphocytes

AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY. 1997 OCT; 17 (4): 414-421

1535

2069 Norris S, Lawler M, McCann S, Hegarty J, OFarrelly C

Donor type microchimerism is an infrequent event following liver transplantation and is not associated with graft acceptance

HEPATOLOGY. 1997 OCT; 26 (4): 848-852

1536

2210 Reed W, Lee TH, Vichinsky EP, Lubin BH, Busch MP

Sample suitability for the detection of minor white cell populations (microchimerism) by polymerase chain reaction

TRANSFUSION. 1998 NOV-DEC; 38 (11-12): 1041-1045

1537

2240 Ravina A, Slezak L, Mirsky N, Anderson RA

Control of steroid-induced diabetes with supplemental chromium

JOURNAL OF TRACE ELEMENTS IN EXPERIMENTAL MEDICINE. 1999; 12 (4): 375-378

1538

2349 Joseph JM, Mosimann F, Tiercy JM, Roux E, Cerottini JP, et al.

PCR confirmation of microchimerism and diagnosis of Graft versus Host Disease after liver transplantation

TRANSPLANT INTERNATIONAL. 1999 NOV; 12 (6): 468-470

1539

2356 Platt JL, Nagayasu T

Current status of xenotransplantation

CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY. 1999 DEC; 26 (12): 1026-1032

1540

2398 Morales JM, Campistol JM, Andres A, Herrero JC

Immunosuppression in older renal transplant patients

DRUGS & AGING. 2000 APR; 16 (4): 279-287

Date / Author / Journal

LCS

GCS

LCR

1541

2417 Jin YD, Fuller L, Esquenazi V, Blomberg BB, Rosen A, et al.

Bone marrow cells inhibit the generation of autologous EBV-specific CTL

HUMAN IMMUNOLOGY. 2000 JUN; 61 (6): 538-547

1542

2434 Groth CG, Brent LB, Calne RY, Dausset JB, Good RA, et al.

Historic landmarks in clinical transplantation: Conclusions from the consensus conference at the University of California, Los Angeles

WORLD JOURNAL OF SURGERY. 2000 JUL; 24 (7): 834-843

108

1543

2451 Morelli AE, Thomson AW

Role of dendritic cells in the immune response against allografts

CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION. 2000 NOV; 9 (6): 607-613

1544

2529 Jin TN, Toki J, Inaba M, Sugiura K, Fan TX, et al.

Novel strategy for organ allografts using sublethal (7 Gy) irradiation followed by injection of donor bone marrow cells via portal vein

TRANSPLANTATION. 2001 JUN 27; 71 (12): 1725-1731

1545

2553 Starzl TE

The "privileged" liver and hepatic tolerogenicity

LIVER TRANSPLANTATION. 2001 OCT; 7 (10): 918-920

1546

2615 Lun A, Cho MY, Muller C, Staffa G, Bechstein WO, et al.

Diagnostic value of peripheral blood T-cell activation and soluble IL-2 receptor for acute rejection in liver transplantation

CLINICA CHIMICA ACTA. 2002 JUN; 320 (1-2): 69-78

1547

2627 Okuda T, Ishikawa T, Azhipa O, Ichikawa N, Demetris AJ, et al.

Early passenger leukocyte migration and acute immune reactions in the rat recipient spleen during liver engraftment: With particular emphasis on donor major histocompatibility complex class II+ cells

TRANSPLANTATION. 2002 JUL 15; 74 (1): 103-111

1548

2675 Muramatsu K, Bishop AT, Sunagawa T, Valenzuela RG

Fate of donor cells in vascularized bone grafts: Identification of systemic chimerism by the polymerase chain reaction

PLASTIC AND RECONSTRUCTIVE SURGERY. 2003 FEB; 111 (2): 763-772

1549

2766 Calne R

Cyclosporine as a milestone in immunosuppression

TRANSPLANTATION PROCEEDINGS. 2004 MAR; 36 (2): 13S-15S

1550

2827 Kuball J, Theobald M, Ferreira EA, Hess G, Burg J, et al.

Control of organ transplant-associated graft-versus-host disease by activated host lymphocyte infusions

TRANSPLANTATION. 2004 DEC 27; 78 (12): 1774-1779

Date / Author / Journal

LCS

GCS

LCR

1551

2920 Migita K, Maeda Y, Abiru S, Nakamura M, Komori A, et al.

Immunosuppressant FK506 inhibits matrix metalloproteinase-9 induction in TNF-u-stimulated human hepatic stellate cells

LIFE SCIENCES. 2006 APR 18; 78 (21): 2510-2515

1552

2943 Thaunat O, Badet L, El-Jaafari A, Kanitakis J, Dubernard JM, et al.

Composite tissue allograft extends a helping hand to transplant immunologists

AMERICAN JOURNAL OF TRANSPLANTATION. 2006 OCT; 6 (10): 2238-2242

1553

2977 Chan EY, Larson AM, Gernsheimer TB, Kowdley KV, Carithers RL, et al.

Recipient and donor factors influence the incidence of graft-vs.-host disease in liver transplant patients

LIVER TRANSPLANTATION. 2007 APR; 13 (4): 516-522

1554

3006 Hsu W, Shu SA, Gershwin E, Lian ZX

The current immune function of hepatic dendritic cells

CELLULAR & MOLECULAR IMMUNOLOGY. 2007 OCT; 4 (5): 321-328

1555

3017 Butt AN, Swaminathan R

Overview of circulating nucleic acids in plasma/serum

CIRCULATING NUCLEIC ACIDS IN PLASMA AND SERUM V. 2008; 1137: 236-242

1556

3044 Gras JM, Gerkens S, Beguin C, Janssen M, Smets F, et al.

Steroid-free, tacrolimus-basiliximab immunosuppression in pediatric liver transplantation: Clinical and pharmacoeconomic study in 50 children

LIVER TRANSPLANTATION. 2008 APR; 14 (4): 469-477

1557

3049 Mehrabi A, Fonouni H, Muller SA, Schmidt J

Current concepts in transplant surgery: liver transplantation today

LANGENBECKS ARCHIVES OF SURGERY. 2008 MAY; 393 (3): 245-260

1558

3076 Tan HP, Donaldson J, Ellis D, Moritz ML, Basu A, et al.

Pediatric Living Donor Kidney Transplantation Under Alemtuzumab Pretreatment and Tacrolimus Monotherapy: 4- Year Experience

TRANSPLANTATION. 2008 DEC 27; 86 (12): 1725-1731

1559

3085 Siemionow M, Klimczak A

Tolerance and Future Directions for Composite Tissue Allograft Transplants: Part II

PLASTIC AND RECONSTRUCTIVE SURGERY. 2009 JAN; 123 (1): 7E-17E

104

1560

3090 Demetris AJ, Lunz JG, Randhawa P, Wu T, Nalesnik M, et al.

Monitoring of human liver and kidney allograft tolerance: a tissue/histopathology perspective

TRANSPLANT INTERNATIONAL. 2009 JAN; 22 (1): 120-141

110

Date / Author / Journal

LCS

GCS

LCR

1561

3094 Spada M, Riva S, Maggiore G, Cintorino D, Gridelli B

Pediatric liver transplantation

WORLD JOURNAL OF GASTROENTEROLOGY. 2009 FEB 14; 15 (6): 648-674

223

1562

3166 Naesens M, Sarwal MM

Molecular diagnostics in transplantation

NATURE REVIEWS NEPHROLOGY. 2010 OCT; 6 (10): 614-628

181

1563

91 ELLIS PP, FONKEN HA

RETINOPATHIES OF CHRONIC GLOMERULONEPHRITIS - A STUDY OF CASES TREATED WITH RENAL TRANSPLANTATION

ARCHIVES OF OPHTHALMOLOGY. 1966; 75 (1): 36-&

1564

120 BILLINGH.RE

TUSSUE TRANSPLANTATION - SCOPE AND PROSPECT

SCIENCE. 1966; 153 (3733): 266-&

1565

149 STARZL TE, MARCHIOR.TL, IWASAKI Y

ATTRIBUTES OF CLINICALLY USED IMMUNOSUPPRESSIVE DRUGS - POSSIBLE FUTURE USES OF ANTILYMPHOID SERA

FEDERATION PROCEEDINGS. 1967; 26 (3): 944-&

1566

211 JAMES K

ANTI-LYMPHOCYTE SERUM

CLINICA CHIMICA ACTA. 1968; 22 (1): 101-&

1567

222 WOLFJURG.P, KOPF AW, LIPKIN G, BART RS

INFLUENCE OF ANTI-LYMPHOCYTE SERUM ON MALIGNANT MELANOMA

JOURNAL OF INVESTIGATIVE DERMATOLOGY. 1968; 51 (6): 441-&

1568

254 DIETHELM AG, DUBERNAR.JM, BUSCH GJ, MURRAY JE

CRITICAL RE-EVALUATION OF IMMUNOSUPPRESSIVE THERAPY IN CANINE RENAL ALLOGRAFTS

SURGERY GYNECOLOGY AND OBSTETRICS WITH INTERNATIONAL ABSTRACTS OF SURGERY. 1968; 126 (4): 723-&

1569

285 FLETCHER EW, LECKY JW

RADIOLOGICAL DEMONSTRATION OF UROLOGICAL COMPLICATIONS IN RENAL TRANSPLANTATION

BRITISH JOURNAL OF RADIOLOGY. 1969; 42 (504): 886-&

1570

325 KASHIWAG.N, GROTH CG, AMEND JR, GECELTER L, BLANCHAR.H, et al.

IMPROVEMENTS IN PREPARATION OF HETEROLOGOUS ANTILYMPHOCYTE GLOBULIN WITH SPECIAL REFERENCE TO ABSORPTION AND DIETHYLAMINOETHYL CELLULOSE BATCH PRODUCTION

SURGERY. 1969; 65 (3): 477-&

Date / Author / Journal

LCS

GCS

LCR

1571

346 GUTTMANN RD, LINDQUIS.RR, OCKNER SA

RENAL TRANSPLANTATION IN INBRED RAT .12. A MECHANISM OF LONG-TERM SURVIVAL OF ALLOGRAFTS AFTER ANTITHYMOCYTE IMMUNOGLOBULIN TREATMENT

TRANSPLANTATION. 1969; 8 (6): 837-&

1572

405 PATTERSO.JT, PISANO JC, DILUZIO NR

REVERSAL OF ANTILYMPHOCYTIC SERUM-INDUCED IMMUNOSUPPRESSION BY MACROPHAGE ADMINISTRATION

PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE. 1970; 135 (3): 831-&

1573

421 WEEKE B, WEEKE E, BENDIXEN G

VARIATION IN 21 SERUM PROTEINS BEFORE AND AFTER RENAL TRANSPLANTATION .2. CHANGES DURING ACUTE REJECTION

ACTA MEDICA SCANDINAVICA. 1971; 189 (1-2): 119-&

1574

431 NOZIK RA, OCONNOR GR

EXPERIMENTAL OCULAR TOXOPLASMOSIS IN RABBIT .3. RECURRENT INFLAMMATION STIMULATED BY SYSTEMIC ADMINISTRATION OF ANTILYMPHOCYTE SERUM AND NORMAL HORSE SERUM

ARCHIVES OF OPHTHALMOLOGY. 1971; 85 (6): 718-&

1575

434 JEEJEEBH.HF

HETEROLOGOUS ANTILYMPHOCYTE SERUM - REVIEW

CANADIAN JOURNAL OF SURGERY. 1971; 14 (1): 5-&

115

1576

478 CHALMERS AH, BURDORF T, MURRAY AW

IMMUNOSUPPRESSION BY 9-ALKYL-6-THIOPURINES

BIOCHEMICAL PHARMACOLOGY. 1972; 21 (19): 2662-&

1577

514 MYBURGH JA, SMIT JA

HEPATIC ALLOTRANSPLANTATION IN BABOON .4. FURTHER STUDIES WITH POST-TRANSPLANT ADMINISTRATION OF DONOR BONE-MARROW AND A SOLUBLE DONOR SPLENIC ANTIGEN

TRANSPLANTATION. 1972; 14 (2): 191-&

1578

583 DUNN DC, RANDALL GK

PROLONGED ALLOGRAFT SURVIVAL FOLLOWING SPONTANEOUS RECOVERY FROM EARLY REJECTION

TRANSPLANTATION. 1974; 17 (3): 306-312

1579

591 MICHEL RP, GUTTMANN RD, KNAACK J, KLASSEN J, BEAUDOIN JG, et al.

ANTILYMPHOCYTE GLOBULIN IN RENAL-TRANSPLANTATION

ARCHIVES OF SURGERY. 1975; 110 (1): 90-93

1580

611 DIETHELM AG, STERLING WA, ALDRETE JS, SHAW JF, MORGAN JM

RETROSPECTIVE ANALYSIS OF 100 CONSECUTIVE PATIENTS UNDERGOING RELATED LIVING DONOR RENAL-TRANSPLANTATION

ANNALS OF SURGERY. 1976; 183 (5): 502-510

Date / Author / Journal

LCS

GCS

LCR

1581

623 SCHUSZIARRA V, ZIEKURSCH V, SCHLAMP R, SIEMENSEN HC

PHARMACOKINETICS OF AZATHIOPRINE UNDER HEMODIALYSIS

INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND BIOPHARMACY. 1976; 14 (4): 298-302

1582

628 ANDERSON B, SAMPSON C, CALLENDER CO

SPONTANEOUS RENAL-ALLOGRAFT RUPTURE WITHOUT REJECTION - CASE-REPORT

JOURNAL OF UROLOGY. 1976; 115 (6): 745-746

1583

732 STARZL TE, KLINTMALM GBG, IWATSUKI S, WEIL R, SCHROTER G

LATE FOLLOW-UP AFTER THORACIC-DUCT DRAINAGE IN CADAVERIC RENAL- TRANSPLANTATION

SURGERY GYNECOLOGY & OBSTETRICS. 1981; 153 (3): 377-382

1584

895 TELLIS VA, MATAS AJ, GLICHLICK D, QUINN T, SOBERMAN R, et al.

CYCLOSPORINE - PRELIMINARY EXPERIENCE IN 79 PATIENTS WITH RENAL-TRANSPLANTS

NEW YORK STATE JOURNAL OF MEDICINE. 1985; 85 (9): 531-534

1585

908 MAKOWKA L, GILAS T, FALK RE, MOFFAT FL, PHILLIPS MJ, et al.

PREVENTION OF CYCLOSPORINE-INDUCED NEPHROTOXICITY IN RATS BY 16,16-DIMETHYL PROSTAGLANDIN-E2

TRANSPLANTATION PROCEEDINGS. 1985; 17 (1): 1381-1383

1586

955 KNECHTLE SJ, KEMPF K, BOLLINGER RR

PEPTIC-ULCER DISEASE FOLLOWING RENAL-TRANSPLANTATION

TRANSPLANTATION PROCEEDINGS. 1987 FEB; 19 (1): 2233-2236

1587

1004 MARGREITER R, BOSMULLER C, SPIELBERGER M, SCHMID T, KONIGSRAINER A

CYCLOSPORINE (CY) MONOTHERAPY AFTER CADAVERIC RENAL-TRANSPLANTATION

TRANSPLANTATION PROCEEDINGS. 1989 FEB; 21 (1): 1591-1593

1588

1013 DIEPERINK H

CYCLOSPORINE-A NEPHROTOXICITY

DANISH MEDICAL BULLETIN. 1989 JUN; 36 (3): 235-248

224

1589

1076 MARINO IR, FERLA G, CELLI S, STIEBER A, MUTTILLO I, et al.

HYPERACUTE REJECTION OF RENAL DISCORDANT XENOGRAFT (PIG-TO-RABBIT) - MODEL ASSESSMENT AND REJECTION MECHANISMS

TRANSPLANTATION PROCEEDINGS. 1990 JUN; 22 (3): 1071-1076

1590

1156 ROSSARO L, MAZZAFERRO V, SCOTTIFOGLIENI CL, WILLIAMS DS, SIMPLACEANU E, et al.

EFFECT OF CYCLOSPORINE ON HEPATIC ENERGY STATUS AND ON FRUCTOSE METABOLISM AFTER PORTACAVAL-SHUNT IN DOG AS MONITORED BY P-31 NUCLEAR- MAGNETIC-RESONANCE SPECTROSCOPY INVIVO

HEPATOLOGY. 1991 APR; 13 (4): 780-785

Date / Author / Journal

LCS

GCS

LCR

1591

1235 HEBERT MF, ASCHER NL, LAKE JR, ROBERTS JP

EFFICACY AND TOXICITY OF FK-506 FOR THE TREATMENT OF RESISTANT REJECTION IN LIVER-TRANSPLANT PATIENTS

TRANSPLANTATION PROCEEDINGS. 1991 DEC; 23 (6): 3109-3110

1592

1272 TAKAORI K, NIO Y, INOUE K, TUN T, FUKUMOTO M, et al.

A COMPARATIVE-STUDY ON IMMUNOSUPPRESSIVE EFFECTS OF CYCLOSPORINE-A AND FK-506 ON PERIPHERAL-BLOOD LYMPHOCYTES IN DOGS

BIOTHERAPY. 1992 MAR; 4 (2): 129-137

1593

1284 HIRAI T, WADA H, HASEGAWA S, INUI K, YOKOMISE H, et al.

THE IMMUNOSUPPRESSIVE EFFECT OF FK-506 ON CANINE LUNG TRANSPLANTATION

JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY. 1992 JUN; 103 (6): 1127-1135

1594

1352 STARZL TE, MURASE N, DEMETRIS AJ, GIORDA R, VALDIVIA L, et al.

DRUG DEVELOPMENT AND TESTING IN RELATION TO CELL-MIGRATION AND CHIMERISM

TRANSPLANTATION PROCEEDINGS. 1993 FEB; 25 (1): 469-472

1595

1364 TAMURA K, WOO J, MURASE N, CARRIERI G, NALESNIK MA, et al.

SUPPRESSION OF AUTOIMMUNE THYROID-DISEASE BY FK-506 - INFLUENCE ON THYROID-INFILTRATING CELLS, ADHESION MOLECULE EXPRESSION AND ANTITHYROGLOBULIN ANTIBODY-PRODUCTION

CLINICAL AND EXPERIMENTAL IMMUNOLOGY. 1993 MAR; 91 (3): 368-375

1596

1384 WINKLER M, SCHULZE F, JOST U, RINGE B, PICHLMAYR R

ANEMIA ASSOCIATED WITH FK-506 IMMUNOSUPPRESSION

LANCET. 1993 APR 17; 341 (8851): 1035-1036

1597

1417 MEISER B, REICHART B

GRAFT VESSEL DISEASE - THE IMPACT OF IMMUNOSUPPRESSION AND POSSIBLE TREATMENT STRATEGIES

IMMUNOLOGICAL REVIEWS. 1993 AUG; 134: 99-116

1598

1516 ABUELMAGD K, TODO S, Tzakis AG, FURUKAWA H, NOUR B, et al.

REJECTION OF HUMAN INTESTINAL ALLOGRAFTS - ALONE OR IN COMBINATION WITH THE LIVER

TRANSPLANTATION PROCEEDINGS. 1994 JUN; 26 (3): 1430-1431

1599

1553 SUGIYAMA E, SUZUKI H, TUNRU IS, YAMASHITA N, HORI T, et al.

FK506, AN IMMUNOSUPPRESSANT, PARTIALLY INHIBITS INTERLEUKIN-6 PRODUCTION BY ADHERENT RHEUMATOID SYNOVIAL- CELLS

JOURNAL OF RHEUMATOLOGY. 1994 SEP; 21 (9): 1597-1601

1600

1700 NISCO SJ, HISSINK RJ, VRIENS PW, HOYT EG, REITZ BA, et al.

IN-VIVO STUDIES OF THE MAINTENANCE OF PERIPHERAL TRANSPLANT TOLERANCE AFTER CYCLOSPORINE - RADIOSENSITIVE ANTIGEN-SPECIFIC SUPPRESSOR CELLS MEDIATE LASTING GRAFT PROTECTION AGAINST PRIMED EFFECTOR-CELLS

TRANSPLANTATION. 1995 MAY 27; 59 (10): 1444-1452

The Kidney Transplant Papers 9 papers representing Starzl's ground breaking work in the area of kidney transplantation. And all the papers citing them from the SCI, AHCI, SSCI databases up-to-date as of May 2012	Historiographs	Glossary HistCite Guide About Grand Totals: LCS 17722, GCS 106366, CR 136943 Collection span: 1963 - 2012
List of All Records